Contraindicated. Coadministration of doravirine with a powerful CYP3A inducer could reduce doravirine plasma concentrations and/or effects. Opportunity for lack of virologic response and doable resistance to doravirine. pentobarbital will reduce the level or result of disopyramide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Not known. With therapeutic do... https://emilyb210qgv8.howeweb.com/profile